Drug Utilization Evaluation on the Combination of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Taiwan

被引：0
|
作者：
Chang, Wen-Yi [1 ]
Chen, Li-Chia [1 ,2 ]
Cheng, Li-Jen [3 ]
机构：
[1] Kaohsiung Med Univ, Grad Inst Clin Pharm, Kaohsiung, Taiwan
[2] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham, England
[3] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
335
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 50 条
  • [21] ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH HYPERTENSION
    Sanchez, Andres M. Cordova
    Shmorgon, Gary
    Olonoff, Danielle A.
    Ramm, Matthew
    Gualan, Carlos Merino
    Chaudhuri, Debanik
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2074 - 2074
  • [22] Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Raebel, Marsha A.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e156 - e166
  • [23] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
  • [24] Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Koomen, E. R.
    Herings, R. M. C.
    Guchelaar, H. J.
    Nijsten, T.
    CANCER EPIDEMIOLOGY, 2009, 33 (05) : 391 - 395
  • [25] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
    Potier, Louis
    Roussel, Ronan
    Elbez, Yedid
    Marre, Michel
    Zeymer, Uwe
    Reid, Christopher M.
    Ohman, Magnus
    Eagle, Kim A.
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    HEART, 2017, 103 (17) : 1339 - 1346
  • [26] Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients
    Kido, Ryo
    Akizawa, Tadao
    Fukagawa, Masafumi
    Onishi, Yoshihiro
    Yamaguchi, Takuhiro
    Fukuhara, Shunichi
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (06) : 439 - 447
  • [27] POTENTIAL DRUG-DRUG INTERACTIONS RELATED TO ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN TAIWAN
    Chang, W. Y.
    Chen, L. C.
    Cheng, L. J.
    VALUE IN HEALTH, 2010, 13 (07) : A523 - A523
  • [28] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Shrimpton, A. J.
    Walker, S. L. M.
    Ackland, G. L.
    BJA EDUCATION, 2020, 20 (11) : 362 - 367
  • [29] Prescribing Trends in Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use in Taiwan, 1998-2007
    Chou, Yi-Ting
    Chang, Chia-Hsuin
    Kuo, Chuei-Wen
    Lai, Mei-Shu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S75 - S76
  • [30] Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 201p
    Sanchis-Gomar, Fabian
    Lavie, Carl J.
    Perez-Quilis, Carme
    Henry, Brandon M.
    Lippi, Giuseppe
    MAYO CLINIC PROCEEDINGS, 2020, 95 (06) : 1222 - 1230
12345